These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 18065735

  • 1. Outcomes after hematopoietic stem-cell transplantation for hematologic malignancies in patients with or without advance care planning.
    Ganti AK, Lee SJ, Vose JM, Devetten MP, Bociek RG, Armitage JO, Bierman PJ, Maness LJ, Reed EC, Loberiza FR.
    J Clin Oncol; 2007 Dec 10; 25(35):5643-8. PubMed ID: 18065735
    [Abstract] [Full Text] [Related]

  • 2. Advance care planning in patients undergoing hematopoietic cell transplantation.
    Joffe S, Mello MM, Cook EF, Lee SJ.
    Biol Blood Marrow Transplant; 2007 Jan 10; 13(1):65-73. PubMed ID: 17222754
    [Abstract] [Full Text] [Related]

  • 3. Disparity in survival outcome after hematopoietic stem cell transplantation for hematologic malignancies according to area of primary residence.
    Rao K, Darrington DL, Schumacher JJ, Devetten M, Vose JM, Loberiza FR.
    Biol Blood Marrow Transplant; 2007 Dec 10; 13(12):1508-14. PubMed ID: 18022581
    [Abstract] [Full Text] [Related]

  • 4. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 10; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 5. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
    Parody R, Martino R, Sánchez F, Subirá M, Hidalgo A, Sierra J.
    Am J Hematol; 2009 Sep 10; 84(9):571-8. PubMed ID: 19676118
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence of delirium and associated mortality in hematopoietic stem cell transplantation patients.
    Beglinger LJ, Duff K, Van Der Heiden S, Parrott K, Langbehn D, Gingrich R.
    Biol Blood Marrow Transplant; 2006 Sep 10; 12(9):928-35. PubMed ID: 16920558
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data.
    Lim Z, Pagliuca A, Simpson S, Cottam S, Ervine M, Ho AY, Devereux S, Mufti GJ.
    Br J Haematol; 2007 Feb 10; 136(3):448-50. PubMed ID: 17156405
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
    Wang Y, Chen F, Han Y, Fu ZZ, Tang XW, Miao M, Qiu HY, Jin ZM, Sun AN, Wu DP.
    Biol Blood Marrow Transplant; 2009 Oct 10; 15(10):1258-64. PubMed ID: 19747633
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M.
    Biol Blood Marrow Transplant; 2009 Feb 10; 15(2):195-204. PubMed ID: 19167679
    [Abstract] [Full Text] [Related]

  • 14. Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies.
    Xiao-Jun H, Lan-Ping X, Kai-Yan L, Dai-Hong L, Yu W, Huan C, Yu-Hong C, Wei H, Jing-Zhi W, Yao C, Xiao-Hui Z, Hong-Xia S, Feng-Rong W, Fei-Fei T.
    Clin Cancer Res; 2009 Jul 15; 15(14):4777-83. PubMed ID: 19584148
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of centre and period effects in allogeneic haematopoietic stem cell transplantation in France.
    Mesnil F, Jouet JP, Tuppin P, Vernant JP, Golmard JL.
    Bone Marrow Transplant; 2004 Oct 15; 34(7):645-51. PubMed ID: 15300230
    [Abstract] [Full Text] [Related]

  • 16. Living-donor lobar lung transplantation for pulmonary complications after hematopoietic stem cell transplantation.
    Yamane M, Sano Y, Toyooka S, Okazaki M, Date H, Oto T.
    Transplantation; 2008 Dec 27; 86(12):1767-70. PubMed ID: 19104419
    [Abstract] [Full Text] [Related]

  • 17. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ, Zhao XY, Huang XJ.
    Biol Blood Marrow Transplant; 2008 Mar 27; 14(3):323-34. PubMed ID: 18275899
    [Abstract] [Full Text] [Related]

  • 18. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy.
    Trifilio SM, Bennett CL, Yarnold PR, McKoy JM, Parada J, Mehta J, Chamilos G, Palella F, Kennedy L, Mullane K, Tallman MS, Evens A, Scheetz MH, Blum W, Kontoyiannis DP.
    Bone Marrow Transplant; 2007 Apr 27; 39(7):425-9. PubMed ID: 17310132
    [Abstract] [Full Text] [Related]

  • 19. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.
    Aki ZS, Sucak GT, Yeğin ZA, Güzel O, Erbaş G, Senol E.
    Transplant Proc; 2008 Jun 27; 40(5):1579-85. PubMed ID: 18589155
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.